Previous studies have extensively examined the utility of NfL as a biomarker for various neurological diseases, including multiple sclerosis (MS) [8], amyotrophic lateral sclerosis (ALS) [9], and Alzheimer’s disease (AD) [10]. The gene discussed is NEFL; the disease is myeloid sarcoma.